1. Home
  2. Live Updates
  3. Prnewswire hepatx corporation

Live Breaking News & Updates on Prnewswire hepatx corporation

Stay informed with the latest breaking news from Prnewswire hepatx corporation on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Prnewswire hepatx corporation and stay connected to the pulse of your community

HepaTx, Namocell, and Takara Bio USA complete second phase of collaboration on single cell analysis for cell therapy to treat late-stage liver diseases


Share this article
Share this article
PALO ALTO, Calif., March 12, 2021 /PRNewswire/ -- HepaTx Corporation, Namocell Inc., and Takara Bio USA, Inc. (TBUSA) announced successful completion of the second phase of their collaboration on single cell analysis of hepatocyte-like cells (iHeps) differentiated from adipose tissue-derived stromal cells (ASCs) using Namocell's Single Cell Dispensers and Takara Bio's SMART-seq® kits to characterize HepaTx's novel cell therapies for liver disease.  The results of the second phase demonstrated a 95% success rate in single cell isolation and library construction.  Single cell RNA-seq showed distinct clusters of cells at various differentiation stages.  The high reproducibility of results within sample groups will support development of novel cell therapies and validate production processes.

Takara-bio , Suvarna-gandlur , Eric-schuur , Jun-yu-lin , Namocell-inc , Takara-bio-inc , Twitter , Takara-bio-united-states-inc , Prnewswire-hepatx-corporation , Takara-bio-united-states , Single-cell-dispensers